Get the Stockscreener App
3.07
0.00%
0.00
After Hours:
3.08
0.01
+0.33%
Stereotaxis Inc stock is traded at $3.07, with a volume of 545.90K.
It is up +0.00% in the last 24 hours and up +7.72% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$3.07
Open:
$3.15
24h Volume:
545.90K
Relative Volume:
0.95
Market Cap:
$279.59M
Revenue:
$25.14M
Net Income/Loss:
$-21.57M
P/E Ratio:
-11.37
EPS:
-0.27
Net Cash Flow:
$-12.23M
1W Performance:
-6.97%
1M Performance:
+7.72%
6M Performance:
+84.94%
1Y Performance:
+55.05%
1-Day Range:
$3.01
$3.2046
1-Week Range:
$3.01
$3.59
52-Week Range:
$1.54
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
3.07 | 279.58M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
Order flow analysis tools used on Stereotaxis Inc.Weekly Trade Report & Technical Confirmation Trade Alerts - newser.com
Stereotaxis (STXS) Partners with CardioFocus to Develop Robotic PFA Technology - GuruFocus
Stereotaxis and CardioFocus partner to develop robotic PFA technology - Investing.com
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias - GlobeNewswire
Can Stereotaxis Inc. stock continue upward trendPortfolio Performance Report & High Return Trade Guides - newser.com
Is Stereotaxis Inc. stock trading at attractive multiplesWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
Stereotaxis Inc Stock Analysis and ForecastInstitutional Holding Changes & Free Explosive Portfolio Gains - earlytimes.in
Can Stereotaxis Inc. stock resist broad market declinesJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
Is Stereotaxis Inc. stock attractive for income investorsRate Cut & Expert Curated Trade Setup Alerts - newser.com
Stereotaxis, Inc. Hits New 52-Week High at USD 3.37 - Markets Mojo
Stereotaxis Inc. stock daily chart insightsPortfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
Can you recover from losses in Stereotaxis Inc.Earnings Risk Summary & Weekly Return Optimization Plans - newser.com
Is Stereotaxis Inc. stock ready for breakoutWeekly Stock Summary & Expert Verified Movement Alerts - newser.com
Key resistance and support levels for Stereotaxis Inc.M&A Rumor & Long-Term Safe Investment Ideas - newser.com
What market sentiment indicators show for Stereotaxis Inc. stockJuly 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
How Stereotaxis Inc. stock stacks up against competitorsJuly 2025 PostEarnings & Free Weekly Chart Analysis and Trade Guides - newser.com
Tools to assess Stereotaxis Inc.’s risk profileJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Stereotaxis, Inc. Hits New 52-Week High at USD 3.20 - Markets Mojo
What analysts say about Stereotaxis Inc stockDividend Growth Stocks & Free Phenomenal Investment Performance - earlytimes.in
What drives Stereotaxis Inc stock pricePrice-to-Book Ratio Updates & Affordable Stock Picks - Early Times
Stereotaxis, Inc. Hits New 52-Week High of $3.07 - Markets Mojo
Clinicians Mark First Use of Stereotaxis MAGIC Sweep Mapping Catheter - Medical Product Outsourcing
Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates - MSN
STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System - sharewise.com
Erasmus MC completes first procedures with Stereotaxis Genesis robot By Investing.com - Investing.com Nigeria
Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System - GlobeNewswire
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.84%
3.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):